Eli Lilly's next generation weight loss drug shows promise, early trial results suggest

Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...

3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 Drugs

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

Eli Lilly cuts surprising deals with upstart biotech players

Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

Novo Nordisk, Lilly strike deal with Trump to slash weight-loss drug prices

The White House is expected to announce a deal for lower prices of obesity drugs from Novo Nordisk and Eli Lilly on Thursday ...
GEN - Genetic Engineering and Biotechnology News

Lilly Expands AI Ties to Insilico, from Customer to Drug Discovery Partner

Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...

2 Reasons I'm Keeping My Eye on Eli Lilly Stock Right Now

Investing in pharmaceutical companies with diversified revenue bases and strong R&D pipelines could be a lucrative strategy.